MARKET

SNY

SNY

Sanofi FR
NASDAQ
41.81
+0.02
+0.04%
Opening 13:27 10/27 EDT
OPEN
41.55
PREV CLOSE
41.79
HIGH
41.97
LOW
41.53
VOLUME
1.33M
TURNOVER
--
52 WEEK HIGH
49.91
52 WEEK LOW
39.07
MARKET CAP
100.17B
P/E (TTM)
22.45
1D
5D
1M
3M
1Y
5Y
1D
Sanofi: An Alluring And Balanced Mix Of Yield And Growth
Seeking Alpha · 1d ago
Sanofi Breaks Ground on New Insulin Manufacturing Facility in Germany
NASDAQ · 1d ago
Sanofi Breaks Ground on High-Tech Insulin Plant in Frankfurt to Bolster Global Supply
TipRanks · 1d ago
Weekly Report: what happened at SNY last week (1019-1023)?
Weekly Report · 1d ago
Earnings Week Ahead: MSFT, GOOGL, AMZN, XOM, BA, VZ, and more
Seeking Alpha · 2d ago
French Bonds Breach 5%, Briefly Overtaking U.S. Treasurys: Why It Matters For American Investors
Benzinga · 3d ago
Sanofi’s New Oral Alzheimer’s Drug Enters Mid-Stage Trials: What Investors Should Watch
TipRanks · 4d ago
Sanofi Advances Rilzabrutinib Kidney Study, Supporting Long-Term BTK Pipeline Potential
TipRanks · 4d ago
More
About SNY
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA (ADR) stock information, including NASDAQ: SNY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNY stock methods without spending real money on the virtual paper trading platform.